Precision Culture Scaling to Establish High‐Throughput Vasculogenesis Models
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202400388 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Nicholas R Dennison und 10 weiteren Autor:innen. Beteiligte Einrichtung: Leibniz Institute of Polymer Research Dresden, Max Bergmann Center of Biomaterials, 01069, Dresden, Germany. Hauptthemen laut MEDLINE: Human Umbilical Vein Endothelial Cells, Neovascularization, Physiologic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, F. Hoffmann-La Roche.
Abstract (Originalsprache)
Hydrogel‐based 3D cell cultures can recapitulate (patho)physiological phenomena ex vivo. However, due to their complex multifactorial regulation, adapting these tissue and disease models for high‐throughput screening workflows remains challenging. In this study, a new precision culture scaling (PCS‐X) methodology combines statistical techniques (design of experiment and multiple linear regression) with automated, parallelized experiments and analyses to customize hydrogel‐based vasculogenesis cultures using human umbilical vein endothelial cells and retinal microvascular endothelial cells. Variations of cell density, growth factor supplementation, and media composition are systematically explored to induce vasculogenesis in endothelial mono‐ and cocultures with mesenchymal stromal cells or retinal microvascular pericytes in 384‐well plate formats. The developed cultures are shown to respond to vasculogenesis inhibitors in a compound‐ and dose‐dependent manner, demonstrating the scope and power of PCS‐X in creating parallelized tissue and disease models for drug discovery and individualized therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leibniz Institute of Polymer Research Dresden, Max Bergmann Center of Biomaterials, 01069, Dresden, Germany.
- Medical Clinic I, University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.
- Ocular Technologies, Immunology, Infectious Diseases and Ophthalmology, Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, 4070, Switzerland.
- Center for Regenerative Therapies Dresden and Cluster of Excellence Physics of Life, Technische Universität Dresden, 01307, Dresden, Germany.
ORCID-Profile: Maximilian Fusenig, Carsten Werner
Förderung
- Deutsche Forschungsgemeinschaft
- F. Hoffmann-La Roche
Zitieren
APA
Dennison, N. R., Fusenig, M., Grönnert, L., Maitz, M. F., Ramirez Martinez, M. A., Wobus, M., Freudenberg, U., Bornhäuser, M., Friedrichs, J., Westenskow, P. D., & Werner, C. (2024). Precision Culture Scaling to Establish High‐Throughput Vasculogenesis Models. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202400388
Vancouver
Dennison NR, Fusenig M, Grönnert L, Maitz MF, Ramirez Martinez MA, Wobus M, et al. Precision Culture Scaling to Establish High‐Throughput Vasculogenesis Models. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202400388
BibTeX
@article{Dennison2024,
author = {Dennison, Nicholas R and Fusenig, Maximilian and Grönnert, Lisa and Maitz, Manfred F and Ramirez Martinez, Maria Alejandra and Wobus, Manja and Freudenberg, Uwe and Bornhäuser, Martin and Friedrichs, Jens and Westenskow, Peter D and Werner, Carsten},
title = {Precision Culture Scaling to Establish High‐Throughput Vasculogenesis Models},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202400388}
}
EUVIMED